IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, giving promising enhancements across a variety of health care and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, much more trusted alternate for therapeutic use, signif